Treatment of HIV associated psoriatic arthritis with oral gold

Journal of Rheumatology

Volumn 23, Issue 10, 1996, Pages 1818-1820

  Shapiro, Deborah L ^a,b   Masci, Joseph R ^a  

^a ELMHURST HOSPITAL CENTER   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

HIV; oral gold; psoriatic arthritis

Indexed keywords

AURANOFIN; CEFAZOLIN; CODEINE; INDOMETACIN; METHOCARBAMOL; NAPROXEN; PARACETAMOL; SULINDAC; TRIAMCINOLONE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAARTICULAR DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIATIC ARTHRITIS;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; AURANOFIN; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS;

EID: 0029804874     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Winchester R, Bernstein DH, Fischer HD, Enlow R, Solomon G: The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 1987;106:19-26.
2. Duvic M, Johnson TM, Rapini R, et al.: Acquired immunodeficiency syndrome: Associated psoriasis and Reiter's syndrome. Arch Dermatol 1987;123:1622-32.
3. Duvic M, Rios A, Brewton GW: Remission of AIDS-associated psoriasis with zidovudine (letter). Lancet 1987;2:621.
4. Espinoza LR, Berman A, Vasey FB, Cahalin C, Nelson R, Germain BF: Psoriatic arthritis and acquired immunodeficiency syndrome. Arthritis Rheum 1988;31:1034-40.
5. Espinoza LR, Aguilar JL, Berman A, Gutierrez F, Vasey FB, Germain BF: Rheumatic manifestations associated with human immunodeficiency virus infection. Arthritis Rheum 1989;32:1615-22.
6. Arnett FC, Reveille JD, Duvic M: Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection. Rheum Dis Clin North Am 1991;17:59-78.
7. Rowe IF, Forster SM, Seifert MH, et al.: Rheumatological lesions in individuals with human immunodeficiency virus infection. Q J Med 1989;272:1167-84.
8. Johnson TM, Duvic M, Rapini RP, Rios A: AIDS exacerbates psoriasis (letter). N Engl J Med 1985;313:1415.
9. Kaplan MH, Sadick NS, Weider J, Farber BF, Neidt GW: Antipsoriatic effects of zidovudine in human immunodeficiency virus-associated psoriasis. J Am Acad Dermatol 1989;20:76-82.
10. Berman A, Espinoza LR, Diaz JD, et al.: Rheumatic manifestations of human immunodeficiency virus infection. Am J Med 1988;35:59-64.
11. Kaye BR: Rheumatologic manifestations of infection with human immunodeficiency virus (HIV). Ann Intern Med 1989;111:158-67.
12. Ruzicka T, Froschl M, Hohenleutner U, et al.: Treatment of HIV-induced retinoid-resistant psoriasis with zidovudine (letter). Lancet 1987;2:1469-70.
13. Keat A, Rowe I: Reiter's syndrome and associated arthritides. Rheum Dis Clin North Am 1991;11:25-42.
14. Palit J, Hill J, Capell HA, et al.: A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate, and placebo in patients with psoriatic arthritis. Br J Rheumatol 1990;29:280-3.
15. Ornstein MH, Kerr LD, Spiera H: A reexamination of the relationship between active rheumatoid arthritis and the acquired immunodeficiency syndrome. Arthritis Rheum 1995;38:1701-6.
16. Blough H, Ricchetti M, Montagnier L, Bue H: Organic gold compounds are effective against HIV-1 reverse transcriptase (abstr). Int Conf AIDS (Montreal, Canada 1989 June 4-9) 5:559.
17. Okada T, Patterson BK, Ye S-Q, Gurney ME: Aurothiolates inhibit HIV-1 infectivity by gold(I) ligand exchange with a component of the virion surface. Virology 1993;192:631-42.
18. 6/1. AIDS 1995;9:145-52.